Accessibility Menu
Arrow-Thin-Down
S&P 500
6,699.40
-0.5%
-35.95
Arrow-Thin-Down
DJI
46,590.41
-0.7%
-334.33
Arrow-Thin-Down
NASDAQ
22,740.40
-0.9%
-213.27
Arrow-Thin-Down
Bitcoin
$107,891
-2.8%
-$3,115.92
Arrow-Thin-Down
AAPL
$258.45
-1.6%
-$4.32
Arrow-Thin-Down
AMZN
$217.92
-1.9%
-$4.11
Arrow-Thin-Down
GOOG
$252.45
+0.4%
+$1.11
Arrow-Thin-Down
META
$733.46
+0.0%
+$0.19
Arrow-Thin-Down
MSFT
$520.63
+0.6%
+$2.97
Arrow-Thin-Down
NVDA
$180.28
-0.5%
-$0.88
Arrow-Thin-Down
TSLA
$438.97
-0.8%
-$3.63
Daily Stock GainersDaily Stock LosersMost Active Stocks
First Trust Exchange-Traded Fund - First Trust Nyse Arca Biotechnology Index Fund Stock Quote

First Trust Exchange-Traded Fund - First Trust Nyse Arca Biotechnology Index Fund (NYSEMKT: FBT)

$187.84
(-0.9%)
-1.78
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$187.84
Daily Change
(-0.9%) $1.78
Day's Range
$187.28 - $189.85
Previous Close
$187.84
Open
$189.01
Beta
0
Volume
13,307
Average Volume
-
Sector
Financials
Market Cap
0
Market Cap / Employee
-
52wk Range
$141.38 - $190.45
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
$0
CAPs Rating
-
Industry
Capital Markets

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

First Trust Exchange-Traded Fund - First Trust Nyse Arca Biotechnology Index Fund Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
FBT+11.4%+21.24%+3.93%+870%
S&P+15.06%+95.03%+14.29%+441%

First Trust Exchange-Traded Fund - First Trust Nyse Arca Biotechnology Index Fund Company Info

The investment seeks investment results that correspond generally to the price and yield (before the fund’s fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM).

News & Analysis

Featured Article

Top Biotech ETFs to Buy Now

Here are the five best biotech ETFs to invest in right now.

Keith Speights  |  Oct 1, 2025
Featured Article

The 4 Top Biotech ETFs

Investing in biotechnology has been very lucrative lately, and these funds can help you tap into the industry's success.

Dan Caplinger  |  Mar 19, 2018

Financial Health

General

No data available for this period.

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

No data available for this period.

Liabilities

No data available for this period.

Ratios

No data available for this period.

Cash Flow

No data available for this period.

Valuation

MetricYoY Change

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services